Choosing among treatment facilities for addiction is one of the most consequential decisions a person or family can make, and the options, terminology, and clinical levels are often needlessly confusing. This practical guide translates ASAM levels into real patient profiles, explains when medical detox is required, and shows how to verify clinical quality, staffing, and medication continuity. You will get a step-by-step checklist of questions to ask admissions, red flags that require escalation, and clear next steps whether you need outpatient medication management, residential care, or inpatient detox.
ASAM Levels of Care and Typical Services
Key point: Correctly mapping a person to an ASAM level prevents both unsafe under-treatment and unnecessary disruption from overly intensive care. Facilities labeled rehab centers for addiction vary widely in what they actually provide; use ASAM as the objective yardstick.
| ASAM Level | What it is / Typical services | Typical duration |
|---|---|---|
| 0.5 – Early Intervention | Screening, brief counseling, referral to higher care when needed | Single session to weeks |
| 1 – Outpatient Addiction Services | Weekly counseling, group therapy, office-based MAT (buprenorphine), case management | Weeks to months |
| 2.1 – Clinically Managed Low-Intensity Residential | Residential structure, counseling, limited medical oversight | Weeks |
| 2.5 – Partial Hospitalization / Day Treatment | Structured daytime programming, medical check-ins, intensive therapy | Days to weeks |
| 3.1 – Clinically Managed Low-Intensity Residential | Longer residential support for stable patients needing housing or structure | Weeks to months |
| 3.3 – Medically Monitored Residential | On-site nursing, daily medical checks, psychotherapy; may manage mild-moderate withdrawal | 2–8 weeks typical |
| 3.5 – Clinically Managed High-Intensity Residential | High staff-to-client ratio, extensive therapeutic programming | Weeks to months |
| 3.7 – Medically Managed Intensive Inpatient | 24/7 physician and nursing care for severe withdrawal, unstable medical/psychiatric status | Days to weeks |
| 4 – Medically Managed Intensive Inpatient Hospital | Acute medical stabilization in a hospital setting; highest medical acuity | Variable; until medically stable |
Who fits which level — practical vignettes
- Outpatient (Level 1): Adult with opioid use disorder, stable housing, motivated for work/school, starts buprenorphine with weekly counseling.
- IOP/Day Program (2.5): Person with heavy alcohol use who needs daily structure and group therapy but not 24/7 nursing.
- Residential (3.3/3.5): Someone homeless with multiple relapses and untreated PTSD who needs housing, intensive therapy, and on-site nursing.
- Inpatient/Detox (3.7/4): Patient with severe alcohol dependence and prior DTs, or benzodiazepine dependence—requires medical withdrawal management.
Concrete Example: A 34-year-old with moderate opioid use and stable family support was started on buprenorphine in an outpatient clinic and attended an intensive outpatient program for three months. When housing destabilized after a relapse, the care team escalated him to a 3.3 residential program with on-site nursing until safe discharge planning was completed.
Trade-off to watch: Higher ASAM levels increase safety and supervision but also cost and disruption to work/family. Many families equate higher level with better care; in practice, continuity of medication and integrated mental health treatment matter more than bed type. Confirm whether a facility continues buprenorphine or coordinates methadone transfer before placing someone.
Practical limitation: Labels like luxury rehabilitation facilities or faith-based rehab programs can mask clinical gaps. Amenities do not substitute for accreditation or on-site medical oversight. Ask admissions for licensure, nurse/physician coverage hours, and whether they follow the ASAM Criteria.
Match clinical need, not appearance. Start with ASAM mapping, then verify medical capabilities and medication policies.
Actionable next step: Use the ASAM level table above while you call admissions. Ask three focused questions: Can you manage acute withdrawal on-site? Do you continue MAT such as buprenorphine? What is your discharge plan for housing and outpatient follow-up?
Next consideration: Before you pick a facility, verify clinical fit against the ASAM level you need and confirm medication continuity and medical coverage during the intended stay.
Medical Detox and Withdrawal Management: When Facility Choice Must Be Medical
Medical detox is not optional for certain patients. People with severe alcohol or benzodiazepine dependence, a history of withdrawal seizures or delirium tremens, unstable cardiac or respiratory disease, pregnancy, or active suicidal ideation need a medically supervised setting with 24 7 clinical oversight.
Key clinical services that distinguish a medical detox facility include continuous vital sign monitoring, nurse-driven withdrawal scoring (CIWA-Ar or COWS), physician orders for scheduled medication tapers, IV access and fluids, thiamine and other repletion, and rapid transfer pathways to higher-level medical care.
Medications and regulatory realities matter in placement decisions. Benzodiazepine tapers and phenobarbital protocols are common for severe alcohol or benzo withdrawal. For opioid use disorder, buprenorphine can often be continued or initiated in many medical settings, while methadone for maintenance is available only through licensed opioid treatment programs – confirm policies before transfer. Ask facilities whether they will continue existing MAT, and how they handle methadone continuity or transfer to an OTP.
Tradeoff to be explicit about. Hospital medical detox minimizes immediate physiologic risk but is costlier and often shorter. Residential detox programs may be more comfortable but sometimes lack ICU backup. Outpatient detoxification saves money and preserves daily responsibilities but is only safe for low-risk patients with reliable supports. Choosing the wrong setting delays definitive treatment or risks medical complications.
Concrete example: A 48 year old with 10 years of heavy alcohol use and a prior withdrawal seizure should not go to a nonmedical residential program. Ideal path: hospital admission or medically supervised detox unit, CIWA-Ar monitoring every 4 hours, benzodiazepine taper per protocol, thiamine, cardiac monitoring as indicated, then direct transfer to an inpatient or intensive outpatient addiction program with MAT or counseling arranged at discharge.
- Admission questions to ask: Do you have a physician and nursing staff on site 24 7?
- Escalation protocol: What is your transfer agreement with a hospital or ICU if needed?
- Medication continuity: Will you continue buprenorphine or coordinate methadone placement at discharge?
- Monitoring and protocols: Do you use CIWA-Ar or COWS, and how often are scores recorded?
- Aftercare linkage: Do you provide warm handoffs to MAT, residential treatment, or outpatient addiction services?
Important: Medical detox reduces immediate risk but is not addiction treatment by itself. Choose a facility that pairs withdrawal management with a clear, documented plan for ongoing care and MAT when appropriate.
How to Match Patient Needs to Level of Care Using Practical Criteria
Direct triage beats checkbox exercises. Mapping a person to the right level of care is a short clinical workflow: combine objective screens, the six ASAM dimensions, and the real-world constraints that will affect safe placement (housing, medications, insurance). Treat ASAM as a decision framework not a fixed algorithm.
Useable translation of the ASAM dimensions
Quick rule: evaluate each ASAM dimension with one concrete measure and one operational question.** Dimension 1 (withdrawal) = ___CODE0 for opioids or CODE1___ for alcohol; Dimension 2 (biomedical) = recent hospitalizations, pregnancy; Dimension 3 (emotional/behavioral) = PHQ-9, active SI/HI; Dimension 4 (readiness) = brief motivation interview plus treatment history; Dimension 5 (environment) = stable housing, safe discharge plan; Dimension 6 (relapse potential) = recent overdoses, polysubstance use, failed outpatient attempts.
- Tools to use at intake: ___CODE0, CODE1___, AUDIT, DAST-10, PHQ-9, GAD-7 — use the smallest battery that answers safety questions quickly.
- Red-flag thresholds: ___CODE0 > 10 or prior DTs/seizures -> medical detox; CODE1___ moderate-severe -> consider supervised management; active suicidal ideation -> inpatient psychiatric placement with addiction capability.
- Context overrides: stable social supports and transportation lower the immediate need for residential care; homelessness, unsafe housing, or recent overdose raise the bar for higher-level placement even if withdrawal scores are low.
A short, practical intake-to-placement checklist
- Safety first: identify imminent medical or psychiatric danger — arrange emergency care if present.
- Score withdrawal risk: apply ___CODE0/CODE1___ and document expected trajectory; if scores or history predict severe withdrawal, prioritize medical detox or hospital-based care.
- Check medications: confirm current MAT (buprenorphine/methadone) and whether the facility will continue it before placement.
- Assess environment: if no safe discharge plan or if legal custody is a factor, prefer residential levels that can provide stabilization and discharge planning.
- Match intensity to treatment history: repeated failed outpatient attempts, recent overdose, or severe polysubstance use -> escalate to residential 3.5/3.7 or inpatient 4 where appropriate.
- Plan continuity: identify next-step outpatient provider and schedule first appointment before discharge to avoid gaps that increase overdose risk.
Concrete example: A 32-year-old with opioid use, stable housing, no severe withdrawal (COWS 4), and adherence to buprenorphine does well in outpatient MAT plus intensive outpatient programming. By contrast, a 45-year-old with recent overdose, no housing, and untreated major depression should be routed to residential care with integrated psychiatric services while housing and stabilization are arranged.
Practical trade-off and judgment: resources and payer rules often constrain ideal placement — accepting a slightly lower level of care is reasonable only when you secure compensating safeguards: guaranteed daily medication access, daily check-ins, and a timed reassessment. Do not place someone into low-intensity care because of convenience alone; that is where relapse and readmission happen.
Common failure mode: relying solely on intake checklists and ignoring the recovery environment. Facilities that score clinical dimensions correctly but discharge to an unsafe or unsupported home will produce poor outcomes. Ask about discharge planning and on-site social work before you commit.
Key takeaway: use objective screens plus a short environment and medication continuity check. If any red flag appears (severe withdrawal risk, active suicidality, no safe discharge plan, recent overdose), escalate to a higher level of care immediately and verify the facility will continue or coordinate medication assisted treatment.
Next consideration: after using this framework to pick a level of care, the next step is to verify the facility can operationalize your safety requirements — ask admissions specific questions about MAT continuity, on-site medical oversight, and discharge planning before finalizing placement.
Evaluating Facility Quality: Accreditation, Staffing, and Evidence Based Care
Start here: when comparing treatment facilities for addiction, accreditation and advertised therapies are entry criteria, not guarantees. The Joint Commission and CARF accreditation plus state licensure are necessary validation steps; they reduce risk but do not replace direct verification of clinical practice, staffing, and medication policies.
What accreditation tells you and what it does not
Accreditation matters because it shows a facility meets baseline standards for safety, recordkeeping, and governance. It does not tell you how clinicians actually manage complex patients, whether the program uses evidence based therapies consistently, or whether patients retain care after discharge. Ask for the accreditation scope and the most recent survey report or corrective action plan.
Staffing you must verify
- Medical leadership: name and credential of the on site medical director – look for board certified addiction medicine or psychiatry, or documented fellowship training
- 24/7 medical coverage: for detox ask who is on call overnight and whether a physician or nurse practitioner is available on site for emergent withdrawal or benzodiazepine complications
- Therapists and counselors: verify licensed clinical social workers, licensed professional counselors, or psychologists for individual therapy and group facilitation
- Medication prescribers: confirm which clinicians prescribe buprenorphine, methadone referrals, or naltrexone and whether state or federal prescribing rules affect continuity
- Peer workforce: ask whether peer recovery specialists are integrated into care and what training or certification they hold
Practical tradeoff: luxury rehab facilities often sell amenities and privacy but some limit medication options or lack integrated psychiatry. If a patient needs MAT or has severe cooccurring mental illness, choose clinical capacity over comfort every time.
Concrete example: a 35 year old on buprenorphine called an inpatient program only to learn the program required tapering off medications during residential stay. The family confirmed this in writing, arranged a different placement that continued buprenorphine, and avoided a medically unnecessary discontinuation that often precipitates relapse.
Evidence based care to look for and how to verify it
- Core therapies: CBT, motivational interviewing, contingency management, and trauma informed approaches are evidence based and should be part of the treatment plan
- Medication assisted treatment: ask what percentage of eligible patients receive MAT and how the program handles continuity at intake and discharge
- Dual diagnosis integration: programs must demonstrate routine psychiatric assessment and collaborative care pathways, not just referral lists
- Outcome data: request retention at 30 and 90 days, MAT continuation rates, and readmission statistics; lack of data is a red flag
What I see fail in practice: facilities will advertise CBT or family therapy but only run occasional groups with junior staff. Insist on a schedule of daily clinical programming and ask who provides high intensity interventions.
Key action: before admission get written answers on accreditation, on site medical coverage, MAT policy, staff credentials, and measurable outcomes. If a facility cannot or will not provide these, treat that as a material concern.
Next check for safety protocols: confirm naloxone distribution policy, overdose response procedures, and transfer agreements with local hospitals. Accreditation plus these operational details is the minimum needed to trust a program with high risk patients.
Do not accept brochure claims. Verify accreditation scope, confirm 24/7 medical oversight for detox, check MAT continuity, and ask for outcome metrics before you commit.
Insurance, Cost, and Admission Logistics
Bottom line: a clinically appropriate placement is meaningless if insurance, prior authorization, or admission rules make it unusable. When you call treatment facilities for addiction, treat the admissions conversation as a simultaneous clinical and financial triage—the two must line up before transport or discharge.
Practical verification checklist
- Call the insurer with the facility name and NPI: confirm in-network status, ask for the specific plan benefit for the intended ASAM level, and record the representative name and reference number.
- Ask about prior authorization and utilization review: get the clinical criteria the insurer will use, the expected review timeline, and the name/phone for peer-to-peer review if needed.
- Confirm medication coverage and continuity: ask explicitly whether buprenorphine, methadone, and naltrexone are covered in the setting you need and whether the facility must be an OTP to continue methadone.
- Get an out-of-pocket estimate: ask what services are excluded, whether lodging or travel is covered for out-of-area placements, and whether the insurer requires preauthorization for each week of stay.
- Document bed-hold and cancellation policies: some programs charge deposits or a hold fee for transfers; get amounts and refund rules in writing.
- Request written authorization: insist on a preauthorization code or email confirmation before arranging transport or discharge.
Trade-off to accept: out-of-network care can deliver a better clinical match or specialized programming, but choosing it without written cost estimates often creates crippling surprise bills. If a facility is noticeably better clinically, negotiate with the facility for a self-pay rate or ask the insurer for out-of-network reimbursement rules before you commit.
Real-world example: a middle-aged patient on office-based buprenorphine needed a short residential stay for housing instability. The residential program agreed to continue buprenorphine, but the insurer required a prior authorization and a peer-to-peer discussion. The family recorded the authorization number, confirmed the facility would accept it, and arranged direct transport the same day to avoid a dose interruption.
Admission logistics that commonly break plans: bed availability and hold policies, gaps in medication access (especially methadone transfers that require an OTP), and missing clinical documentation that triggers retroactive denials. Expect the facility to request recent clinical notes, withdrawal scales, and a medication list; delays in sending those can cost days of coverage.
If the insurer denies prior authorization, request a peer-to-peer review and escalate to appeals immediately while keeping the placement option open.
Request a single point-of-contact: an assigned admissions coordinator plus the insurer case manager. That two-way relationship is the fastest route to resolving authorizations, medication continuity, and transport logistics.
Next consideration: if you hit resistance, use SAMHSA resources or your state behavioral health office for help with funding options, expedited placement, or crisis grants—do not assume the first insurer response is final.
Choosing for Specific Populations and Special Needs
Start from clinical requirements, not marketing. Different populations need different clinical capabilities and operational policies – a program that works for a middle aged adult with stable housing will often fail a pregnant person, adolescent, veteran, or someone with severe mental illness.
Core mismatches to avoid
Key point: Specialized needs create predictable failure modes. Common mismatches include programs that restrict medication assisted treatment for opioid use disorder, residential sites that will not accept pregnant patients, adolescent programs without family therapy, and general rehabs that lack on-site psychiatric coverage for severe mental illness.
- Pregnancy: confirm prenatal care coordination and continuation of buprenorphine or methadone; ask about obstetrics partnerships and neonatal planning
- Adolescents: confirm family therapy, school liaison services, and age-appropriate group programming rather than placing minors in adult wards
- Co-occurring severe mental illness: require integrated psychiatric care or an inpatient psychiatric unit that also provides addiction treatment
- Veterans: look for facilities that accept VA benefits or have formal referral pathways with VA behavioral health services
- LGBTQ and gender diverse patients: verify existence of culturally competent staff, non-discrimination policies, and experience with gender-affirming care
- People experiencing homelessness: prioritize programs with housing navigation, social work for benefits, and flexible discharge planning
Trade-off to accept: Highly specialized programs improve fit and outcomes but often have longer wait times, stricter admission criteria, and narrower insurance networks. Choosing a less-specialized but immediately available option can be the right clinical move when the risk of delay is high.
Concrete example: A pregnant person presenting in active opioid use needs a program that continues buprenorphine, links to prenatal care, and prepares for neonatal care. In practice this meant choosing an outpatient MAT clinic that coordinated same-day OB intake and arranged a warm handoff to a hospital-based neonatal team rather than waiting two weeks for a local residential bed that did not continue MOUD.
Practical check: Before you commit, get these answers in writing from admissions: does the facility continue MOUD, what psychiatric services are on-site, do you accept minors or pregnant patients, what is the discharge plan for housing and benefits, and what documentation will be shared with primary care or OB providers. If admissions cannot answer, treat that as a red flag.
If dual diagnosis or pregnancy is present, prioritize medical and psychiatric integration over amenities. Accreditation and nice facilities matter less than on-site medical oversight, continuity of essential medications, and clear protocols for high-risk populations.
Where to look next: For guidelines on matching level of care to clinical need consult the ASAM Criteria and use the SAMHSA treatment locator to filter by services such as adolescent programs, pregnancy-friendly care, or dual diagnosis treatment.
Next consideration: Verify a facility will provide a written, population-specific discharge and contingency plan before admission – that single document reveals whether the program actually coordinates the medical, social, and legal pieces your person will need after treatment.
Transition, Aftercare, and Measuring Facility Success
Transition is the highest-risk phase of treatment. A good facility treats discharge as a clinical handoff, not an administrative checkbox: medication continuity, a scheduled outpatient appointment, and a named contact for crises reduce early relapse and readmission.
Core aftercare elements facilities should provide
- Medication continuity: written plan for home medications and a confirmed appointment for MAT within 72 hours if needed
- Scheduled outpatient follow up: name, date, and time for the first outpatient visit with a clinician who has the chart
- Recovery supports: peer recovery specialist assignment, community support meetings referrals, and sober living options when housing is unstable
- Family and social plan: at least one family session or caregiver briefing and crisis contacts
- Documentation transfer: immediate electronic transfer of relevant records to receiving provider and primary care
Trade-off to know: high-quality warm handoffs cost time and staff. Facilities that promise same-day placement everywhere are often glossing over real capacity limits. Prioritize programs that document how they will bridge care rather than accept blanket promises.
What to request when measuring facility success
| Metric | What to ask the facility | How to interpret it in practice |
|---|---|---|
| 30/90/180-day retention | Request retention numbers with denominators and the definition used | Retention shows engagement but not necessarily reduced harm; low follow up capture biases results upward |
| MAT continuation rate | Ask what percent of patients on buprenorphine or methadone continue at 30/90 days | A high continuation rate indicates good medication handoff; verify whether prescriptions were actually filled |
| Readmission and adverse events | Request readmission rates and how the facility tracks overdoses post discharge | Facilities may underreport events that occur outside their system; ask about data sources |
| Functional outcomes | Ask about measures for housing stability, employment, or legal involvement at follow up | These are more meaningful long term but are rarely collected reliably |
Real-world example: A 28-year-old completed a 21-day residential program and needed buprenorphine. The facility scheduled a warm handoff to an outpatient clinic, faxed recent labs and medication history, and confirmed an intake appointment within 48 hours. The receiving clinic continued buprenorphine, set weekly counseling, and the peer recovery specialist checked in twice during week one. That sequence materially reduced early dropout in practice.
Judgment that matters: published success rates mean little without transparency on measurement. Prefer facilities that share methodology, allow third-party verification, or provide follow up rates rather than headline percentages. In practice, continuity of care and documented warm handoffs predict better short-term outcomes more reliably than curated abstinence statistics.
Measure success by continuity and actionable handoffs, not by a single percentage number.
Key action: before you commit, get a written 30-day transition plan with a named clinician, scheduled MAT appointment if applicable, and a peer or case manager contact. If a facility will not produce that, treat it as a red flag.
Next practical step: ask admissions to export the facility’s follow up protocol and the exact metrics they track. If they cannot or will not share this, you will have to assume weak transition processes and plan for additional community supports yourself.